TH588 --- MTH1 Inhibitor


Catalog No. size PriceQuantity
M60211-2S 2 mg solid $139
M60211-10S 10mg solid $556

Description

TH588 is a novel potent, selective and cell permeable inhibitor of the nudix hydrolase family MTH1 protein with an IC50 of ~5 nM. Protein co-crystal structures demonstrate that TH588 binds in the active site of MTH1. It has excellent selectivity over other nudix family proteins and kinases present in the selectivity panel. The MTH1 protein sanitizes oxidized dNTP pools to prevent incorporation of damaged bases during DNA replication. Although MTH1 is non-essential in normal cells, the cancer cells require MTH1 activity to avoid incorporation of oxidized dNTPs. MTH1 inhibition by TH588 causes incorporation of oxidized dNTPs in cancer cells, leading to DNA damage, cytotoxicity and therapeutic responses in patient-derived mouse xenografts. TH588 is a good chemical tool to exemplify the non-oncogene addiction concept for anticancer treatment and validate MTH1 as a drug target.

Product information

CAS Number: 1609960-31-7

Molecular Weight: 295.17

Formula: C13H12Cl2N4

Chemical Name: N4-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine

Smiles: NC1N=C(C=C(NC2CC2)N=1)C1=CC=CC(Cl)=C1Cl

InChiKey: PNMYJIOQIAEYQL-UHFFFAOYSA-N

InChi: InChI=1S/C13H12Cl2N4/c14-9-3-1-2-8(12(9)15)10-6-11(17-7-4-5-7)19-13(16)18-10/h1-3,6-7H,4-5H2,(H3,16,17,18,19)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO up to 50 mM

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined.

HS Tariff Code: 382200

How to use

In Vitro:

TH588 was used at 5-10 µM final concentration in various in vitro assays.

In Vivo:

TH588 was dosed to the mice by subcutaneous administration at 30 mg/kg once per day for 21 days. Formulation is 10% N-methylpyrrilidone, 90% PEG300.

References:

  1. Gad H, et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. (2014) Nature. 508(7495):215-21.

Products are for research use only. Not for human use.

Payment & Security

American Express Diners Club Discover JCB Mastercard PayPal Venmo Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed